TALPHERA, INC. Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss
TALPHERA, INC. (TLPH) reported Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Other Income
us-gaap:MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-08-12
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-06-30 was $0.00.
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2026-03-31 was $0.00.
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-12-31 was $0.00.
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-09-30 was $0.00.
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was $0.00.
- TALPHERA, INC. marketable securities, gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was $0.00.
| Period end | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-12-31 | $0.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2026-08-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-03-23 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |